TrialLancet (London, England)2016

Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.

Peter M Villiger et al.PubMed ↗Publisher ↗

No numbers read from the abstract.